Spontaneous malignant transformation of melanocytes explanted from Wf/Wf mice with a Kit kinase-domain mutation.
about
Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosisImmunohistochemical determination of HER-2/neu overexpression in malignant melanoma reveals no prognostic value, while c-Kit (CD117) overexpression exhibits potential therapeutic implicationsNUAK2 Amplification Coupled with PTEN Deficiency Promotes Melanoma Development via CDK Activation.Rac1 drives melanoblast organization during mouse development by orchestrating pseudopod- driven motility and cell-cycle progression.Tissue inducible Lifeact expression allows visualization of actin dynamics in vivo and ex vivoRor2 enhances polarity and directional migration of primordial germ cells.Driver mutations in melanoma: lessons learned from bench-to-bedside studiesSpecific analysis of KIT and PDGFR-alpha expression and mutational status in Merkel cell carcinoma.The molecular basis of human piebaldism.Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development.Activated mutant NRas(Q61K) drives aberrant melanocyte signaling, survival, and invasiveness via a Rac1-dependent mechanism.Phenotypic reversions at the W/Kit locus mediated by mitotic recombination in mice.Phosphorylation of BRN2 modulates its interaction with the Pax3 promoter to control melanocyte migration and proliferation.recessive spotting: a linked locus that interacts with W/Kit but is not allelic.Genetic variation at KIT locus may predispose to melanoma.Identification of a novel cDNA clone encoding protein tyrosine kinase in murine skin.
P2860
Q22001442-78EEABF7-8365-419F-BC79-D6C8D791EE6EQ24798111-D0FEF37E-44E1-4758-AD3F-D9287C60CF71Q27348507-F26F9E7C-69DE-466A-B739-9FEE7BE9F660Q30525522-7E07CBFC-71FF-4683-AFC1-A34A57C57C2FQ30572348-D43C30BA-A186-4699-8762-2754D3EA4C55Q34116880-B5F2A22C-3E7A-477E-98D4-744A634059B3Q34639532-B2EF6C85-D956-4849-AE9B-5B1E2C577E67Q34690237-89682BF3-CC7F-4740-AFB3-6B7104241B6EQ35200359-EC94F641-70CC-4EC4-A728-839E593B04B6Q36103651-A58C4AAD-BB2E-4F25-8439-FCB29946E82AQ36321208-F8346412-64D9-4FBC-841C-22E9EC749BD3Q36555613-54B5114F-939D-4825-8CE4-B35B4D02BB5AQ39404040-FD4E1DCC-664C-4BF3-93E0-4FC7D9BFF81AQ41025697-92477BE2-B436-40DA-8ACB-129FD60CEA77Q43415112-E77BADF1-5AB7-40D7-A842-738C775FF46BQ48080526-9331E579-ED19-4720-AF31-2DFF62CCB227
P2860
Spontaneous malignant transformation of melanocytes explanted from Wf/Wf mice with a Kit kinase-domain mutation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 1992
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Spontaneous malignant transfor ...... a Kit kinase-domain mutation.
@en
Spontaneous malignant transfor ...... a Kit kinase-domain mutation.
@nl
type
label
Spontaneous malignant transfor ...... a Kit kinase-domain mutation.
@en
Spontaneous malignant transfor ...... a Kit kinase-domain mutation.
@nl
prefLabel
Spontaneous malignant transfor ...... a Kit kinase-domain mutation.
@en
Spontaneous malignant transfor ...... a Kit kinase-domain mutation.
@nl
P2093
P2860
P356
P1476
Spontaneous malignant transfor ...... a Kit kinase-domain mutation.
@en
P2093
P2860
P304
P356
10.1073/PNAS.89.16.7816
P407
P577
1992-08-01T00:00:00Z